Else Nutrition Holdings Management

Management criteria checks 2/4

Else Nutrition Holdings' CEO is Hamutal Yitzhak, appointed in Jun 2019, has a tenure of 4.83 years. total yearly compensation is CA$354.64K, comprised of 77.2% salary and 22.8% bonuses, including company stock and options. directly owns 9.16% of the company’s shares, worth CA$3.31M. The average tenure of the management team and the board of directors is 4.8 years and 4.5 years respectively.

Key information

Hamutal Yitzhak

Chief executive officer

CA$354.6k

Total compensation

CEO salary percentage	77.2%
CEO tenure	4.8yrs
CEO ownership	9.2%
Management average tenure	4.8yrs
Board average tenure	4.5yrs

Recent management updates

Recent updates

Is Else Nutrition Holdings (TSE:BABY) Weighed On By Its Debt Load?

Apr 06

Health Check: How Prudently Does Else Nutrition Holdings (TSE:BABY) Use Debt?

Aug 15

Here's Why We're Watching Else Nutrition Holdings' (TSE:BABY) Cash Burn Situation

Dec 20

We Think Else Nutrition Holdings (TSE:BABY) Needs To Drive Business Growth Carefully

Aug 23

Will Else Nutrition Holdings (TSE:BABY) Spend Its Cash Wisely?

Jan 28

Here's Why We're Watching Else Nutrition Holdings' (CVE:BABY) Cash Burn Situation

Oct 20

We Think Else Nutrition Holdings (CVE:BABY) Can Afford To Drive Business Growth

Jul 13

CEO Compensation Analysis

How has Hamutal Yitzhak's remuneration changed compared to Else Nutrition Holdings's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	n/a	n/a	-CA$16m
Sep 30 2023	n/a	n/a	-CA$16m
Jun 30 2023	n/a	n/a	-CA$21m
Mar 31 2023	n/a	n/a	-CA$18m
Dec 31 2022	CA$355k	CA$274k	-CA$18m
Sep 30 2022	n/a	n/a	-CA$10m
Jun 30 2022	n/a	n/a	-CA$8m
Mar 31 2022	n/a	n/a	-CA$11m
Dec 31 2021	CA$341k	CA$275k	-CA$2m
Sep 30 2021	n/a	n/a	-CA$18m
Jun 30 2021	n/a	n/a	-CA$21m
Mar 31 2021	n/a	n/a	-CA$20m
Dec 31 2020	CA$307k	CA$254k	-CA$24m
Sep 30 2020	n/a	n/a	-CA$11m
Jun 30 2020	n/a	n/a	-CA$9m
Mar 31 2020	n/a	n/a	-CA$7m
Dec 31 2019	CA$261k	CA$129k	-CA$5m

Compensation vs Market: Hamutal's total compensation ($USD259.31K) is above average for companies of similar size in the Canadian market ($USD174.55K).

Compensation vs Earnings: Hamutal's compensation has increased whilst the company is unprofitable.

CEO

Hamutal Yitzhak (54 yo)

4.8yrs

Tenure

CA$354,644

Compensation

Ms. Hamutal Yitzhak serves as Chief Executive Officer and Chairman of the Board at Else Nutrition Holdings Inc since June 12, 2019 and has been its Director since June 12, 2019. She is Co-Founder of Else N...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Hamutal Yitzhak	Co-Founder	4.8yrs	CA$354.64k	9.16% CA$ 3.3m
Uriel Kesler	Co-Founder	4.8yrs	CA$354.64k	9.16% CA$ 3.3m
Shay Shamir	CFO & Corporate Secretary	4.8yrs	CA$229.79k	no data
Michael Azar	Co-Founder & CTO	4.8yrs	CA$233.34k	2.04% CA$ 735.0k
Reuben Halevi	Vice President of Sales Operations	4.8yrs	CA$220.68k	0.28% CA$ 101.3k
Liliana Frimerman	Head of Bookkeeping & Payroll	no data	no data	no data

4.8yrs

Average Tenure

62yo

Average Age

Experienced Management: BABY's management team is considered experienced (4.8 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Hamutal Yitzhak	Co-Founder	4.8yrs	CA$354.64k	9.16% CA$ 3.3m
Uriel Kesler	Co-Founder	4.8yrs	CA$354.64k	9.16% CA$ 3.3m
Sukvinder Puar	Non-Independent Director	9yrs	CA$188.20k	0.039% CA$ 14.0k
Eli Ronen	Independent Director	4.4yrs	CA$38.55k	no data
Ofer Barash	Independent Director	3.3yrs	CA$50.25k	no data
Satwinder Mann	Independent Director	4.8yrs	CA$23.71k	0.45% CA$ 162.5k
Akash Bedi	Independent Director	4.1yrs	no data	no data
Jon Vanderhoof	Member of Advisory Board	4.5yrs	no data	no data
Raanan Shamir	Member of Advisory Board	no data	no data	no data
Ron Shaoul	Member of Advisory Board	no data	no data	no data
Hania Szajewska	Member of Scientific Advisory Board	3yrs	no data	no data
Carina Venter	Member of Scientific Advisory Board	3yrs	no data	no data

4.5yrs

Average Tenure

59yo

Average Age

Experienced Board: BABY's board of directors are considered experienced (4.5 years average tenure).

Else Nutrition Holdings Management

Management criteria checks 2/4

Key information

Recent management updates

Else Nutrition Holdings Inc., Annual General Meeting, Jun 12, 2024

Else Nutrition Holdings Inc. Appoints Yaki Lutski to the Board of Directors

High number of new directors

Vice President of Sales Operations recently sold CA$134k worth of stock

High number of new and inexperienced directors

Else Nutrition Holdings Inc., Annual General Meeting, Jun 30, 2022

Recent updates

Else Nutrition Holdings Inc., Annual General Meeting, Jun 12, 2024

Is Else Nutrition Holdings (TSE:BABY) Weighed On By Its Debt Load?

Full year 2023 earnings released: CA$0.13 loss per share (vs CA$0.16 loss in FY 2022)

Else Nutrition Holdings Inc. Launches Ready-To-Drink Kids Shakes on One of Canada's Largest Online Retail Platform

Else Nutrition Holdings Inc. Launches Toddler and Kids Products in over 150 Stores of a Major Retail Chain Providing Potential Access to 2,000 US Stores

Else Announces Online Launch of Its Kids Ready-To-Drink Plant-Powered Shakes with One of Largest Retailers

ELSE NUTRITION HOLDINGS INC. Further Penetrates Canadian Market with Leading Retail Pharmacy Chain Listing of Ready-To-Drink Product

Else Nutrition Holdings Inc. Completes its First Large-Scale Production Run of its Ready-to-Drink Kids Shakes

Else Nutrition Holdings Inc. has completed a Composite Units Offering in the amount of CAD 5.005 million.

Else Nutrition Holdings Inc. has completed a Composite Units Offering in the amount of CAD 5.005 million.

Else Nutrition Holdings Inc. Launches Full Product Range in the Canadian Retail Locations of One of the World's Largest Retailers of Organic and Natural Foods

Third quarter 2023 earnings released: EPS: CA$0.009 (vs CA$0.032 loss in 3Q 2022)

Else Nutrition Holdings Inc. Provides Revenue Guidance for the Fourth Quarter of 2023

Else Nutrition Holdings Inc. to Report Q3, 2023 Results on Nov 14, 2023

Else Nutrition Holdings Inc. Announces the Launch of Its Highly Acclaimed, Plant-Based Complete Nutrition Toddler Drink in the United Kingdom

New minor risk - Share price stability

Else Nutrition Holdings Inc.'S Ready-To-Drink Kids Shakes Approved for Sale by Leading Online Marketplace

Else Nutrition Holdings Inc. Announces the Introduction of its First-Ever Ready-To-Drink (Rtd) Kids Nutritional Shakes

New minor risk - Shareholder dilution

Second quarter 2023 earnings released: CA$0.032 loss per share (vs CA$0.013 loss in 2Q 2022)

Health Check: How Prudently Does Else Nutrition Holdings (TSE:BABY) Use Debt?

Else Nutrition Holdings Inc. to Report Q2, 2023 Results on Aug 14, 2023

Else Nutrition Holdings Inc. Announces to Launch Its First-Ever Ready-To-Drink (RTD) Products in the Form of Kids Nutritional Shakes in Vanilla and Chocolate Flavors

Else Nutrition Holdings Inc. Achieves Another WIC Approval: Oklahoma Welcomes Kids Shakes and Toddler Nutrition Products

Else Nutrition Holdings Inc.'s Plant-Based Kids Shakes Now Approved by the Arizona Women, Infants, and Children Program

Else Nutrition Holdings Inc. Appoints Yaki Lutski to the Board of Directors

Else Nutrition Holdings Inc. Expands Baby, Toddler, and Kids Nutrition Choices Nationwide

First quarter 2023 earnings released: CA$0.07 loss per share (vs CA$0.069 loss in 1Q 2022)

Else Nutrition Holdings Inc. to Report Q1, 2023 Results on May 15, 2023

Else Nutrition Holdings Inc. Receives IRB Approval for Infant Growth Clinical Study Protocol

Else Nutrition Holdings Inc. announced that it expects to receive $13.75 million in funding from The Lind Partners, LLC

Here's Why We're Watching Else Nutrition Holdings' (TSE:BABY) Cash Burn Situation

Third quarter 2022 earnings released: CA$0.032 loss per share (vs CA$0.015 loss in 3Q 2021)

High number of new directors

Else Nutrition Holdings Inc. to Report Q3, 2022 Results on Nov 14, 2022

Else Nutrition Holdings Inc. Kids Products Launch At Retail

Price target increased to CA$4.50

We Think Else Nutrition Holdings (TSE:BABY) Needs To Drive Business Growth Carefully

Second quarter 2022 earnings released: CA$0.013 loss per share (vs CA$0.05 loss in 2Q 2021)

Else Nutrition Holdings Inc. to Report Q2, 2022 Results on Aug 15, 2022

Else Nutrition Holdings Inc. has completed a Composite Units Offering in the amount of CAD 7.287 million.

Else Nutrition Holdings Inc. Successfully Completes Second Preclinical Study on the Path for FDA Approval

Else Nutrition Holdings Inc. Successfully Completes Second Preclinical Study on the Path for FDA Approval

Vice President of Sales Operations recently sold CA$134k worth of stock

Else Nutrition Holdings Inc. Announces Soy Free Infant Formula in Advance of FDA Approval

Else Nutrition Holdings Inc. Announces Soy Free Infant Formula in Advance of FDA Approval

First quarter 2022 earnings released: CA$0.069 loss per share (vs CA$0.023 profit in 1Q 2021)

Else Nutrition Holdings Inc. Provides Revenue Guidance for the Second Quarter of 2022

Else Nutrition Holdings Inc. Provides Earnings Guidance for the Second Quarter of 2022

Else Nutrition Holdings Inc. Receives Approval for Its Novel Plant-Based Complete Nutrition for Toddlers & Kids to Be Listed At Lassens Natural Food & Vitamins Stores

Else Nutrition Holdings Inc. to Report Q1, 2022 Results on May 16, 2022

Else Nutrition Holdings Inc. Receives Formal Listing Approval for Its Novel

Price target decreased to CA$3.00

High number of new and inexperienced directors

Else Nutrition Holdings Inc. Provides Revenue Guidance for the Second Quarter of 2022

Else Nutrition Holdings Inc. Releases the First-Ever U.S. Certified Baby Cereal - Safe of Heavy Metals

Else Nutrition Holdings Inc., Annual General Meeting, Jun 30, 2022

Else Nutrition Holdings Inc. Announces That Rouses Markets Has Added Two Additional Products Else Plant-Based Kids Shakes, in Chocolate and Vanilla Flavors

Else Nutrition Holdings Inc. Announces Launch of Else Toddler Nutrition

Full year 2021 earnings released: CA$0.017 loss per share (vs CA$0.30 loss in FY 2020)

Else Nutrition Holdings Inc. Provides Revenue Guidance for the First Quarter of 2022

Else Nutrition Holdings Inc. Concludes Successful Preclinical Study on Its Plant-Based Infant Formula, on Pathway to Bring Its Formulation to Market

Else Nutrition Holdings Inc. Appoints Susan Baker to Scientific Advisory Board

Else Nutrition Holdings Inc. Appoints Carlos Lifschitz to its Scientific Advisory Board

Bo Lönnerdal, Joins Else Nutrition Holdings Inc.'s Scientific Advisory Board

Else Nutrition Holdings Inc Expands Else Kids Nutrition Product Line with 4 New Flavors to Be Potentially Carried Across 30,000 Stores

Will Else Nutrition Holdings (TSE:BABY) Spend Its Cash Wisely?

Else Nutrition Holdings Inc. Adds Kids Nutrition Products at Sprouts Farmers Market Retail Stores Across the U.S

Third quarter 2021 earnings: EPS in line with expectations, revenues disappoint